Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cellectar Biosc (NQ: CLRB )

1.120 USD UNCHANGED
Streaming Delayed Price Updated: 11:32 AM EDT, Jul 29, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 194,440
Open 1.120
Bid (Size) 1.120 (2)
Ask (Size) 1.140 (21)
Prev. Close 1.120
Today's Range 1.100 - 1.140
52wk Range 1.010 - 2.980
Shares Outstanding 52,726,278
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Cellectar Announces Expansion of Ongoing Collaboration Agreement with IntoCell Inc.
Preclinical Data Supports Further Development of Multiple Novel Phospholipid Drug Conjugates (PDCs) 
From GlobeNewswire News Releases
Cellectar Announces a Co-Development and Commercialization Collaboration with LegoChemBio for New Small Molecule Phospholipid Drug Conjugates (PDCs)
Development of Multiple Novel PDCs 
From GlobeNewswire News Releases

Performance

YTD
-45.89%
-45.89%
1 Month
-13.85%
-13.85%
3 Month
-28.66%
-28.66%
6 Month
-41.05%
-41.05%
1 Year
-18.84%
-18.84%

More News

Read More
Cellectar to Participate in the Ladenburg Thalmann 2021 Virtual Healthcare Conference
From GlobeNewswire News Releases
Cellectar Announces the Election of Dr. Asher Alban Chanan-Khan to Its Board of Directors
From GlobeNewswire News Releases
Cellectar Presents Data in Waldenstrom’s Macroglobulinemia in Poster at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
From GlobeNewswire News Releases
Cellectar Announces Poster Presentation of CLR 131 Data in Waldenstrom’s Macroglobulinemia at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
From GlobeNewswire News Releases
Cellectar to Participate at the Oppenheimer Rare & Orphan Disease Summit on May 21, 2021
From GlobeNewswire News Releases
Cellectar Reports Financial Results for the First Quarter 2021 and Provides a Corporate Update
From GlobeNewswire News Releases
Cellectar, LegoChemBio Team Up To Develop Phospholipid Drug Conjugates For Solid Tumors
Tags News CLRB Biotech
From Benzinga
Cellectar Strengthens Global IP Position with Phospholipid Drug Conjugate Composition of Matter Patent in Eurasia, Australia, and Mexico
From GlobeNewswire News Releases
Thinking about buying stock in indie Semiconductor, CohBar, Cellectar Biosciences, Lucira Health, or Dare Bioscience?
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]